Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004426 · ClinicalTrials.gov registry record · NA
Leuprolide in Determining the Cause of Gonadotropin Deficiency
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00004426: Completed NA study, sponsored by University of Chicago.
NCT00004426 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004426, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
RATIONALE: The body's response to one injection of leuprolide may provide more information than the standard test for gonadotropin deficiency in determining whether the cause of gonadotropin deficiency is related to the hypothalamus or the pituitary gland. PURPOSE: Randomized double-blinded clinical trial to study the effectiveness of leuprolide in determining the cause of gonadotropin deficiency.
Interventions
- DRUG leuprolide
- DRUG gonadotropin releasing hormone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 1994-08 |
| Est. Completion | 1998-09 |
| Phase | NA |
What the finished NCT00004426 record still lists
NCT00004426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which leuprolide is the first listed.
NCT00004426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004426 about?
NCT00004426 is a clinical study titled "Leuprolide in Determining the Cause of Gonadotropin Deficiency". RATIONALE: The body's response to one injection of leuprolide may provide more information than the standard test for gonadotropin deficiency in determining whether the cause of gonadotropin deficiency is related to the hypothalamus or the pituitary gland. PURPOSE: Randomized double-blinded clinica...
What is the current status of trial NCT00004426?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 1994-08. Estimated completion is 1998-09.
What interventions are being tested in trial NCT00004426?
The interventions under investigation include: leuprolide (DRUG), gonadotropin releasing hormone (DRUG).
Who is sponsoring clinical trial NCT00004426?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00004426's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia